Chen He1, Zhiyuan Zhang2, Yinan Ding1, Kangli Xue1, Xihui Wang1, Rui Yang3, Yanli An1, Dongfang Liu1, Chunmei Hu4, Qiusha Tang5. 1. Medical School of Southeast University, 87 Dingjiaqiao Road, Nanjing, China. 2. Department of Neurosurgery, Nanjing Jinling Hospital, Nanjing University, Nanjing, China. 3. Research Institute for Reproductive Health and Genetic Diseases, The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University, Wuxi, China. 4. Department of Tuberculosis, the Second Affiliated Hospital of Southeast University, Nanjing, China. hcm200702@163.com. 5. Medical School of Southeast University, 87 Dingjiaqiao Road, Nanjing, China. panyixi-tqs@163.com.
Abstract
BACKGROUND: Glioblastoma (GBM) is the most invasive primary intracranial tumor, and its effective treatment is one of the most daunting challenges in oncology. The blood-brain barrier (BBB) is the main obstacle that prevents the delivery of potentially active therapeutic compounds. In this study, a new type of pH-sensitive polymersomes has been designed for glioblastoma therapy to achieve a combination of radiotherapy and chemotherapy for U87-MG human glioblastoma xenografts in nude mice and significantly increased survival time. RESULTS: The Au-DOX@PO-ANG has a good ability to cross the blood-brain barrier and target tumors. This delivery system has pH-sensitivity and the ability to respond to the tumor microenvironment. Gold nanoparticles and doxorubicin are designed as a complex drug. This type of complex drug improve the radiotherapy (RT) effect of glioblastoma. The mice treated with Au-DOX@PO-ANG NPs have a significant reduction in tumor volume. CONCLUSION: In summary, a new pH-sensitive drug delivery system was fabricated for the treatment of glioblastoma. The new BBB-traversing drug delivery system potentially represents a novel approach to improve the effects of the treatment of intracranial tumors and provides hope for glioblastoma treatment.
BACKGROUND:Glioblastoma (GBM) is the most invasive primary intracranial tumor, and its effective treatment is one of the most daunting challenges in oncology. The blood-brain barrier (BBB) is the main obstacle that prevents the delivery of potentially active therapeutic compounds. In this study, a new type of pH-sensitive polymersomes has been designed for glioblastoma therapy to achieve a combination of radiotherapy and chemotherapy for U87-MGhumanglioblastoma xenografts in nude mice and significantly increased survival time. RESULTS: The Au-DOX@PO-ANG has a good ability to cross the blood-brain barrier and target tumors. This delivery system has pH-sensitivity and the ability to respond to the tumor microenvironment. Gold nanoparticles and doxorubicin are designed as a complex drug. This type of complex drug improve the radiotherapy (RT) effect of glioblastoma. The mice treated with Au-DOX@PO-ANG NPs have a significant reduction in tumor volume. CONCLUSION: In summary, a new pH-sensitive drug delivery system was fabricated for the treatment of glioblastoma. The new BBB-traversing drug delivery system potentially represents a novel approach to improve the effects of the treatment of intracranial tumors and provides hope for glioblastoma treatment.
Authors: Shota Tanaka; David N Louis; William T Curry; Tracy T Batchelor; Jorg Dietrich Journal: Nat Rev Clin Oncol Date: 2012-11-27 Impact factor: 66.675
Authors: Beatrice Formicola; Alessia D'Aloia; Roberta Dal Magro; Simone Stucchi; Roberta Rigolio; Michela Ceriani; Francesca Re Journal: Front Bioeng Biotechnol Date: 2019-12-12
Authors: Marta Orlicka-Płocka; Agnieszka Fedoruk-Wyszomirska; Dorota Gurda-Woźna; Paweł Pawelczak; Patrycja Krawczyk; Małgorzata Giel-Pietraszuk; Grzegorz Framski; Tomasz Ostrowski; Eliza Wyszko Journal: Antioxidants (Basel) Date: 2021-06-12